marketcaparena
Search

    CDNA

    CareDx, Inc.

    Company overview

    Market capitalization
    $3.34B
    Employees
    761
    Latest publication
    2026-09-29
    About CareDx, Inc.

    CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; and AlloHeme, a monitoring test that predicts relapse in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, the company provides QTYPE that enables precision in human leukocyte antigen (HLA) typing; Olerup SSP, which is used to type HLA alleles based on sequence specific primer technology; and Ottr, a transplant patient management software. Further, it offers AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a solution that monitors the pharmacokinetics of engraftment and persistence of cells for patients who have received allogeneic cell therapy; and XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems software solutions. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ1 20212021-03-31 · USDQ4 20142014-12-31 · USDQ3 20142014-09-30 · USDQ2 20142014-06-30 · USDQ1 20142014-03-31 · USD
    Total Revenue131,948,000USD117,700,000USD100,055,000USD67,400,000USD7,952,000USD6,654,000USD6,776,000USD5,924,000USD
    Cost Of Revenue20,260,000USD33,629,000USD31,309,000USD21,579,000USD2,204,000USD1,772,000USD2,403,000USD2,162,000USD
    Gross Profit111,688,000USD84,071,000USD68,746,000USD45,821,000USD5,748,000USD4,882,000USD4,373,000USD3,762,000USD
    Research Development22,376,000USD21,416,000USD16,768,999USD16,004,000USD1,298,000USD1,036,000USD792,000USD720,000USD
    Selling And Marketing Expenses33,441,000USD30,373,000USD—15,452,000USD1,635,000USD1,753,000USD1,610,000USD1,474,000USD
    General And Administrative Expenses40,908,000USD———————
    Total Operating Expenses18,725,000USD82,273,000USD66,733,999USD46,679,000USD5,282,000USD4,765,000USD4,718,000USD3,989,000USD
    Operating Income113,223,000USD1,798,000USD2,012,000USD-858,000USD429,000USD1,393,000USD-345,000USD-227,000USD
    Total Other Income Expense Net1,295,000USD979,000USD-352,000USD-92,000USD-434,000USD-180,000USD-278,000USD-1,077,000USD
    Income Before Tax114,518,000USD2,777,000USD1,660,000USD-950,000USD-5,000USD1,213,000USD-623,000USD-1,304,000USD
    Income Tax Expense3,882,000USD-32,000USD-15,000USD-263,000USD268,000USD-873,000USD-1,500,000USD548,000USD
    Net Income110,636,000USD2,809,000USD1,675,000USD-687,000USD-5,000USD1,213,000USD877,000USD-1,304,000USD
    Selling General Administrative—30,484,000USD28,429,000USD15,223,000USD2,349,000USD1,976,000USD2,316,000USD1,795,000USD
    Interest Income—1,909,000USD2,013,000USD126,000USD————
    Net Interest Income—1,909,000USD2,013,000USD126,000USD————
    Tax Provision—-32,000USD-15,000USD-263,000USD————
    Net Income From Continuing Ops—2,809,000USD1,675,000USD-687,000USD781,000USD1,213,000USD877,000USD0USD
    Ebit—2,777,000USD1,660,000USD-858,000USD466,000USD117,000USD-345,000USD-227,000USD
    Ebitda—8,095,000USD6,823,000USD1,769,000USD624,000USD249,000USD-229,000USD-121,000USD
    Depreciation And Amortization—5,318,000USD5,163,000USD2,627,000USD158,000USD132,000USD116,000USD106,000USD
    Reconciled Depreciation—5,318,000USD5,163,000USD2,627,000USD158,000USD132,000USD116,000USD106,000USD
    Unclassified Operating Expenses——21,536,000USD—————
    Interest Expense———126,000USD389,000USD535,000USD644,000USD548,000USD
    Non Operating Income Net Other———-218,000USD—355,000USD366,000USD—
    Net Income Applicable To Common Shares———-687,000USD-432,000USD1,213,000USD877,000USD0USD
    Minority Interest————279,000USD0USD0USD0USD
    Discontinued Operations————0USD0USD0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue333,785,000USD27,306,000USD
    Cost Of Revenue109,630,000USD8,541,000USD
    Gross Profit224,155,000USD18,765,000USD
    Research Development72,405,000USD3,846,000USD
    Selling General Administrative123,784,000USD8,436,000USD
    Unclassified Operating Expenses-12,799,000USD—
    Total Operating Expenses183,390,000USD18,754,000USD
    Operating Income40,765,000USD1,250,000USD
    Interest Income11,765,000USD—
    Net Interest Income11,765,000USD—
    Income Before Tax52,859,000USD-719,000USD
    Income Tax Expense310,000USD-1,500,000USD
    Tax Provision310,000USD—
    Net Income52,549,000USD781,000USD
    Net Income From Continuing Ops52,549,000USD781,000USD
    Ebit-53,752,000USD11,000USD
    Ebitda-33,995,000USD523,000USD
    Depreciation And Amortization19,757,000USD512,000USD
    Reconciled Depreciation19,757,000USD—
    Total Other Income Expense Net12,094,000USD-1,969,000USD
    Selling And Marketing Expenses—6,472,000USD
    Interest Expense—2,116,000USD
    Non Operating Income Net Other—147,000USD
    Minority Interest—279,000USD
    Net Income Applicable To Common Shares—781,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets532,988,000USD411,062,000USD413,228,000USD432,307,000USD444,257,000USD489,638,000USD491,050,000USD476,985,000USD
    Cash And Equivalents373,636,000USD———————
    Cash And Short Term Investments373,636,000USD187,176,000USD177,208,000USD194,217,000USD186,255,000USD230,917,000USD260,653,000USD240,853,000USD
    Short Term Investments0USD109,253,000USD111,779,000USD102,782,000USD118,043,000USD142,172,000USD145,964,000USD145,453,000USD
    Long Term Investments0USD10,901,000USD24,165,000USD———0USD—
    Total Current Assets429,223,000USD269,395,000USD257,132,000USD300,280,000USD307,296,000USD350,239,000USD351,832,000USD334,087,000USD
    Other Current Assets14,228,000USD11,230,000USD10,591,000USD29,891,000USD25,764,000USD24,908,000USD7,071,000USD7,344,000USD
    Other Non Current Assets5,679,000USD———————
    Total Liabilities107,390,000USD———————
    Total Current Liabilities93,698,000USD79,153,000USD89,849,000USD99,044,000USD93,180,000USD85,284,000USD89,371,000USD81,440,000USD
    Other Non Current Liabilities406,000USD———————
    Total Stockholder Equity425,598,000USD313,535,000USD303,101,000USD311,140,000USD327,370,000USD379,349,000USD378,433,000USD273,246,000USD
    Total Equity Including Noncontrolling Interest425,598,000USD———————
    Net Receivables34,377,000USD44,585,000USD42,628,000USD47,844,000USD67,362,000USD71,485,000USD64,605,000USD66,627,000USD
    Inventory6,982,000USD26,404,000USD26,705,000USD28,328,000USD27,915,000USD22,929,000USD19,503,000USD19,263,000USD
    Property Plant Equipment Net43,041,000USD54,362,000USD55,731,000USD54,892,000USD57,306,000USD59,119,000USD57,892,000USD59,838,000USD
    Goodwill35,968,000USD———————
    Intangible Assets18,556,000USD32,102,000USD31,960,000USD33,445,999USD36,037,000USD37,247,000USD38,184,000USD40,361,000USD
    Accounts Payable9,493,000USD9,066,000USD9,988,000USD11,597,000USD9,863,000USD8,072,000USD7,686,000USD6,239,000USD
    Common Stock51,000USD51,000USD50,000USD51,000USD53,000USD51,000USD51,000USD50,000USD
    Retained Earnings-505,446,000USD-732,550,000USD-735,359,000USD-719,047,000USD-695,161,000USD-636,595,000USD-626,242,000USD-704,252,000USD
    Accumulated Other Comprehensive Income0USD-6,272,000USD-5,515,000USD-5,954,999USD-6,113,000USD-7,089,000USD-8,569,000USD-7,179,000USD
    Total Liab—97,527,000USD110,127,000USD121,167,000USD116,887,000USD110,289,000USD112,617,000USD203,739,000USD
    Other Current Liab—57,871,000USD68,693,000USD75,252,000USD71,023,000USD65,585,000USD70,734,000USD63,525,000USD
    Capital Stock—51,000USD50,000USD51,000USD53,000USD51,000USD51,000USD50,000USD
    Good Will—40,336,000USD40,336,000USD40,336,000USD40,336,000USD40,336,000USD40,336,000USD40,336,000USD
    Cash—77,923,000USD65,429,000USD91,435,000USD68,212,000USD88,745,000USD114,689,000USD95,400,000USD
    Current Deferred Revenue—5,555,000USD4,653,000USD5,763,000USD5,952,000USD5,422,000USD4,848,000USD5,552,000USD
    Net Debt—-53,425,000USD-39,235,000USD-63,791,000USD-39,090,000USD-58,468,000USD-86,323,000USD-65,435,000USD
    Short Term Debt—6,661,000USD6,515,000USD6,432,000USD6,342,000USD6,205,000USD6,103,000USD6,124,000USD
    Short Long Term Debt Total—24,498,000USD26,194,000USD27,644,000USD29,122,000USD30,277,000USD28,366,000USD29,965,000USD
    Property Plant Equipment Gross—54,362,000USD94,582,000USD54,892,000USD57,306,000USD59,119,000USD94,834,000USD59,838,000USD
    Common Stock Shares Outstanding—53,129,928shares51,124,846shares53,736,790shares54,304,754shares55,262,459shares58,221,755shares52,903,000shares
    Non Current Assets Total—141,667,000USD156,096,000USD132,027,000USD136,961,000USD139,399,000USD139,218,000USD142,898,000USD
    Non Current Liabilities Total—18,374,000USD20,278,000USD22,123,000USD23,707,000USD25,005,000USD23,246,000USD122,299,000USD
    Non Current Liabilities Other—407,000USD418,000USD794,000USD796,000USD804,000USD819,000USD96,946,000USD
    Non Currrent Assets Other—14,867,000USD28,069,000USD3,353,000USD3,282,000USD2,697,000USD2,806,000USD2,363,000USD
    Net Working Capital—190,242,000USD167,283,000USD201,236,000USD214,116,000USD264,955,000USD262,461,000USD252,647,000USD
    Unclassified Non Current Assets—-10,901,000USD-24,165,000USD—————
    Unclassified Non Current Liabilities—17,967,000USD19,860,000USD21,329,000USD22,911,000USD24,201,000USD22,427,000USD25,353,000USD
    Unclassified Equity—1,052,255,000USD1,043,875,000USD1,036,039,999USD1,028,538,000USD1,022,931,000USD1,013,142,000USD984,577,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets413,228,000USD491,050,000USD466,826,000USD542,991,000USD566,621,000USD368,511,000USD151,736,000USD130,697,000USD
    Intangible Assets31,960,000USD38,184,000USD45,701,000USD43,051,000USD50,195,000USD44,355,000USD45,541,000USD33,252,000USD
    Other Current Assets10,591,000USD7,071,000USD7,763,000USD9,216,000USD7,928,000USD3,758,000USD3,628,000USD3,590,000USD
    Total Liab110,127,000USD112,617,000USD205,498,000USD112,080,000USD100,745,000USD90,832,000USD52,736,000USD34,769,000USD
    Total Stockholder Equity303,101,000USD378,433,000USD261,328,000USD430,911,000USD465,876,000USD277,679,000USD99,000,000USD95,928,000USD
    Other Current Liab68,693,000USD70,734,000USD54,509,000USD55,100,000USD55,798,000USD33,505,000USD22,619,000USD14,754,000USD
    Common Stock50,000USD51,000USD49,000USD52,000USD52,000USD49,000USD42,000USD41,000USD
    Capital Stock50,000USD51,000USD49,000USD52,000USD52,000USD49,000USD42,000USD41,000USD
    Retained Earnings-735,359,000USD-626,242,000USD-678,269,000USD-460,444,000USD-383,189,000USD-352,527,000USD-333,813,000USD-311,845,000USD
    Good Will40,336,000USD40,336,000USD40,336,000USD37,523,000USD36,983,000USD23,857,000USD23,857,000USD12,005,000USD
    Cash65,429,000USD114,689,000USD82,197,000USD89,921,000USD348,485,000USD134,669,000USD38,223,000USD64,616,000USD
    Cash And Short Term Investments177,208,000USD260,653,000USD235,418,000USD293,089,000USD348,485,000USD224,703,000USD38,223,000USD64,616,000USD
    Total Current Assets257,132,000USD351,832,000USD313,713,000USD387,849,000USD433,360,000USD273,097,000USD71,922,000USD81,114,000USD
    Total Current Liabilities89,849,000USD89,371,000USD78,072,000USD75,975,000USD77,301,000USD69,217,000USD34,828,000USD19,504,000USD
    Current Deferred Revenue4,653,000USD4,848,000USD4,748,000USD5,342,000USD4,208,000USD24,026,000USD3,686,000USD39,000USD
    Net Debt-39,235,000USD-86,323,000USD-47,976,000USD-50,924,000USD-327,133,000USD-116,567,000USD-32,836,000USD-64,444,000USD
    Short Term Debt6,515,000USD6,103,000USD5,943,000USD5,591,000USD3,958,000USD2,033,000USD3,017,000USD172,000USD
    Short Long Term Debt Total26,194,000USD28,366,000USD34,221,000USD38,997,000USD21,352,000USD18,102,000USD5,387,000USD172,000USD
    Long Term Investments24,165,000USD0USD——————
    Short Term Investments111,779,000USD145,964,000USD153,221,000USD203,168,000USD0USD90,034,000USD——
    Net Receivables42,628,000USD64,605,000USD51,061,000USD66,312,000USD59,761,000USD34,624,000USD24,057,000USD9,760,000USD
    Inventory26,705,000USD19,503,000USD19,471,000USD19,232,000USD17,186,000USD10,012,000USD6,014,000USD4,943,000USD
    Accounts Payable9,988,000USD7,686,000USD12,872,000USD9,942,000USD13,337,000USD9,653,000USD5,506,000USD4,711,000USD
    Property Plant Equipment Net55,731,000USD57,892,000USD65,137,000USD70,218,000USD40,037,000USD25,932,000USD9,160,000USD4,134,000USD
    Property Plant Equipment Gross94,582,000USD94,834,000USD97,400,000USD70,218,000USD40,037,000USD25,932,000USD9,160,000USD4,134,000USD
    Accumulated Other Comprehensive Income-5,515,000USD-8,569,000USD-6,963,000USD-7,503,000USD-4,670,000USD-2,096,000USD-5,205,000USD-4,278,000USD
    Common Stock Shares Outstanding53,287,546shares56,621,000shares53,764,705shares53,321,625shares52,241,076shares46,481,772shares42,151,617shares35,638,956shares
    Non Current Assets Total156,096,000USD139,218,000USD153,113,000USD155,142,000USD133,261,000USD95,414,000USD79,814,000USD49,583,000USD
    Non Current Liabilities Total20,278,000USD23,246,000USD127,426,000USD36,105,000USD23,444,000USD21,615,000USD17,908,000USD15,265,000USD
    Non Current Liabilities Other418,000USD819,000USD96,551,000USD249,000USD23,029,000USD20,316,000USD15,935,000USD11,136,000USD
    Non Currrent Assets Other28,069,000USD2,806,000USD1,939,000USD4,350,000USD6,046,000USD1,270,000USD1,256,000USD-3,494,000USD
    Net Working Capital167,283,000USD262,461,000USD235,641,000USD311,874,000USD356,059,000USD203,880,000USD37,094,000USD61,610,000USD
    Unclassified Non Current Assets-24,165,000USD——-4,350,000USD-6,046,000USD-1,270,000USD-1,256,000USD—
    Unclassified Non Current Liabilities19,860,000USD22,427,000USD30,875,000USD33,157,000USD-6,050,000USD-5,546,000USD-14,830,000USD-15,265,000USD
    Unclassified Equity1,043,875,000USD1,013,142,000USD946,462,000USD898,754,000USD853,631,000USD632,204,000USD437,934,000USD411,969,000USD
    Other Assets——-17,789,000USD4,350,000USD6,046,000USD1,270,000USD1,256,000USD192,000USD
    Other Liab———2,699,000USD6,050,000USD5,546,000USD14,830,000USD15,265,000USD
    Net Tangible Assets———350,337,000USD378,698,000USD209,467,000USD29,602,000USD50,671,000USD
    Deferred Long Term Liab————415,000USD1,299,000USD1,973,000USD4,129,000USD
    Unclassified Current Assets———————-1,795,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income2,809,000USD-4,108,000USD1,675,000USD-8,568,000USD-10,353,000USD78,010,000USD-950,000USD-4,623,000USD
    Depreciation5,318,000USD5,260,000USD5,163,000USD5,053,000USD4,940,000USD4,688,000USD4,889,000USD4,957,000USD
    Stock Based Compensation9,803,000USD8,091,000USD8,418,000USD9,424,000USD8,931,000USD26,198,000USD7,236,000USD16,399,000USD
    Other Non Cash Items1,046,000USD-64,000USD3,244,000USD226,000USD876,000USD-295,000USD588,000USD-420,000USD
    Change To Account Receivables-2,078,000USD5,306,000USD19,551,000USD4,304,000USD-6,640,000USD1,809,000USD-343,000USD-6,008,000USD
    Change To Inventory-346,000USD2,034,000USD-252,000USD-4,067,000USD-2,674,000USD-1,312,000USD519,000USD1,049,000USD
    Change In Working Capital-14,643,000USD12,167,000USD18,858,000USD3,760,000USD-30,978,000USD-86,712,000USD759,000USD2,636,000USD
    Total Cash From Operating Activities4,333,000USD21,363,000USD37,358,000USD9,895,000USD-26,584,000USD21,889,000USD12,522,000USD18,949,000USD
    Capital Expenditures-3,819,000USD-1,630,000USD-1,305,000USD-1,007,000USD-1,630,000USD-1,522,000USD-1,685,000USD-1,790,000USD
    Free Cash Flow514,000USD19,733,000USD36,053,000USD8,888,000USD-28,214,000USD20,367,000USD10,837,000USD17,159,000USD
    Investments14,878,000USD-32,942,000USD12,349,000USD23,397,000USD1,325,000USD-2,111,000USD-14,406,000USD-11,626,000USD
    Total Cashflows From Investing Activities11,059,000USD-34,913,000USD12,349,000USD23,397,000USD1,325,000USD-2,111,000USD-14,406,000USD-11,626,000USD
    Total Cash From Financing Activities-2,911,000USD-12,462,000USD-26,478,000USD-53,811,000USD-643,000USD-903,000USD1,422,000USD-4,850,000USD
    Sale Purchase Of Stock991,000USD-12,205,000USD-25,563,000USD-50,000,000USD873,000USD-3,567,000USD5,517,000USD-3,598,000USD
    Change In Cash12,494,000USD-26,006,000USD23,223,000USD-20,532,000USD-25,979,000USD19,282,000USD-378,000USD2,488,000USD
    Begin Period Cash Flow65,980,000USD91,986,000USD68,212,000USD89,295,000USD115,274,000USD95,992,000USD96,370,000USD93,882,000USD
    End Period Cash Flow78,474,000USD65,980,000USD91,435,000USD68,763,000USD89,295,000USD115,274,000USD95,992,000USD96,370,000USD
    Other Cashflows From Financing Activities-4,011,000USD-1,670,000USD-1,147,000USD-3,811,000USD-4,565,000USD-6,517,000USD-2,634,000USD-4,973,000USD
    Other Cashflows From Investing Activities—-1,971,000USD-1,980,000USD-1,007,000USD-1,630,000USD-2,156,000USD-4,962,000USD-9,836,000USD
    Unclassified Investing Cash Flow—1,630,000USD3,285,000USD2,014,000USD3,260,000USD3,678,000USD6,647,000USD11,626,000USD
    Unclassified Financing Cash Flow—1,413,000USD——3,049,000USD9,181,000USD-1,461,000USD3,721,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-21,354,000USD52,549,000USD-190,284,000USD-76,613,000USD-30,662,000USD-18,714,000USD-21,968,000USD-46,781,000USD
    Depreciation20,416,000USD19,757,000USD19,824,000USD16,007,000USD11,885,000USD9,544,000USD7,144,000USD4,215,000USD
    Stock Based Compensation34,864,000USD66,406,000USD49,086,000USD46,553,000USD36,081,000USD23,401,000USD22,417,000USD7,138,000USD
    Other Non Cash Items4,282,000USD1,830,000USD-3,609,000USD3,031,000USD298,000USD309,000USD51,000USD33,899,000USD
    Change To Account Receivables22,521,000USD-13,741,000USD16,016,000USD-6,660,000USD-24,416,000USD-10,402,000USD-12,675,000USD-3,967,000USD
    Change To Inventory-4,959,000USD-1,018,000USD54,000USD-2,859,000USD-6,927,000USD-3,196,000USD-1,270,000USD363,000USD
    Change In Working Capital3,807,000USD-102,307,000USD106,029,000USD-14,217,000USD-40,970,000USD17,396,000USD-10,413,000USD-871,000USD
    Total Cash From Operating Activities42,032,000USD38,048,000USD-18,388,000USD-25,239,000USD-19,294,000USD33,431,000USD-2,769,000USD-4,007,000USD
    Capital Expenditures-5,913,000USD-6,484,000USD-9,240,000USD-24,334,000USD-20,259,000USD-10,360,000USD-3,349,000USD-7,237,000USD
    Free Cash Flow36,119,000USD31,564,000USD-27,628,000USD-49,573,000USD-39,553,000USD23,071,000USD-6,118,000USD-11,244,000USD
    Investments8,746,000USD-483,000USD40,446,000USD-228,502,000USD83,405,000USD-90,034,000USD-1,000,000USD-7,929,000USD
    Total Cashflows From Investing Activities2,158,000USD-483,000USD40,446,000USD-228,502,000USD47,712,000USD-100,394,000USD-22,579,000USD-7,929,000USD
    Total Cash From Financing Activities-93,394,000USD-5,606,000USD-29,606,000USD-4,535,000USD185,642,000USD163,149,000USD-132,000USD50,268,000USD
    Sale Purchase Of Stock-87,768,000USD-522,000USD-27,541,000USD-642,000USD2,139,000USD1,368,000USD760,000USD287,000USD
    Change In Cash-49,294,000USD32,491,000USD-7,660,000USD-258,253,000USD213,757,000USD96,460,000USD-26,329,000USD38,334,000USD
    Begin Period Cash Flow115,274,000USD82,783,000USD90,443,000USD348,696,000USD134,939,000USD38,479,000USD64,808,000USD26,474,000USD
    End Period Cash Flow65,980,000USD115,274,000USD82,783,000USD90,443,000USD348,696,000USD134,939,000USD38,479,000USD64,808,000USD
    Other Cashflows From Investing Activities-6,588,000USD-634,000USD1,495,000USD-206,658,000USD-35,693,000USD-10,360,000USD-3,349,000USD-5,202,000USD
    Other Cashflows From Financing Activities-13,621,000USD-5,084,000USD-2,065,000USD-3,893,000USD-3,147,000USD5,197,000USD40,000USD11,842,000USD
    Unclassified Investing Cash Flow5,913,000USD7,118,000USD7,745,000USD230,992,000USD20,259,000USD10,360,000USD-14,881,000USD12,439,000USD
    Unclassified Financing Cash Flow7,995,000USD———188,855,000USD158,135,000USD3,658,000USD79,383,000USD
    Net Borrowings——0USD0USD-66,000USD-183,000USD-172,000USD-14,484,000USD
    Issuance Of Capital Stock——0USD0USD188,855,000USD158,135,000USD—52,910,000USD
    Change To Liabilities———-2,269,000USD19,995,000USD13,037,000USD7,495,000USD4,881,000USD
    Dividends Paid————-2,139,000USD-1,368,000USD-4,418,000USD-26,760,000USD
    Cash And Cash Equivalents Changes————214,060,000USD96,186,000USD-25,480,000USD38,332,000USD
    Unclassified Operating Cash Flow————4,074,000USD1,495,000USD—-1,607,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational5,322,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States126,626,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductPatient And Digital Solutions19,230,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct12,791,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductServices99,927,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational4,054,000USD0001217234-26-000033
    Q1 2026Quarterly · 2026-03-31GeographyUnited States113,646,000USD0001217234-26-000033
    Q1 2026Quarterly · 2026-03-31ProductPatient And Digital Solutions15,956,000USD0001217234-26-000033
    Q1 2026Quarterly · 2026-03-31ProductProduct10,346,000USD0001217234-26-000033
    Q1 2026Quarterly · 2026-03-31ProductServices91,398,000USD0001217234-26-000033
    Q4 2025Quarterly · 2025-12-31ProductPatient And Digital Solutions16,757,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct13,256,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductServices78,373,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational19,866,000USD0001217234-26-000018
    FY 2025Yearly · 2025-12-31GeographyUnited States359,939,000USD0001217234-26-000018
    FY 2025Yearly · 2025-12-31ProductPatient And Digital Solutions56,933,000USD0001217234-26-000018
    FY 2025Yearly · 2025-12-31ProductProduct48,377,000USD0001217234-26-000018
    FY 2025Yearly · 2025-12-31ProductServices274,495,000USD0001217234-26-000018
    Q3 2025Quarterly · 2025-09-30GeographyRest of World4,997,000USD0001217234-25-000063
    Q3 2025Quarterly · 2025-09-30GeographyUnited States95,058,000USD0001217234-25-000063
    Q3 2025Quarterly · 2025-09-30ProductPatient And Digital Solutions15,409,000USD0001217234-25-000063
    Q3 2025Quarterly · 2025-09-30ProductProduct12,478,000USD0001217234-25-000063
    Q3 2025Quarterly · 2025-09-30ProductServices72,168,000USD0001217234-25-000063
    Q2 2025Quarterly · 2025-06-30GeographyRest of World5,038,000USD0001217234-25-000046
    Q2 2025Quarterly · 2025-06-30GeographyUnited States81,641,000USD0001217234-25-000046
    Q2 2025Quarterly · 2025-06-30ProductPatient And Digital Solutions12,813,000USD0001217234-25-000046
    Q2 2025Quarterly · 2025-06-30ProductProduct11,833,000USD0001217234-25-000046
    Q2 2025Quarterly · 2025-06-30ProductServices62,033,000USD0001217234-25-000046
    Q1 2025Quarterly · 2025-03-31GeographyInternational4,820,000USD0001217234-26-000033
    Q1 2025Quarterly · 2025-03-31GeographyUnited States79,865,000USD0001217234-26-000033
    Q1 2025Quarterly · 2025-03-31ProductPatient And Digital Solutions11,954,000USD0001217234-26-000033
    Q1 2025Quarterly · 2025-03-31ProductProduct10,810,000USD0001217234-26-000033
    Q1 2025Quarterly · 2025-03-31ProductServices61,921,000USD0001217234-26-000033
    Q4 2024Quarterly · 2024-12-31ProductPatient And Digital Solutions11,393,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct11,367,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductServices63,819,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyEurope10,669,000USD0001217234-25-000012
    FY 2024Yearly · 2024-12-31GeographyRest of World5,384,000USD0001217234-25-000012
    FY 2024Yearly · 2024-12-31GeographyUnited States317,732,000USD0001217234-25-000012
    FY 2024Yearly · 2024-12-31ProductPatient And Digital Solutions43,621,000USD0001217234-26-000018
    FY 2024Yearly · 2024-12-31ProductProduct40,783,000USD0001217234-26-000018
    FY 2024Yearly · 2024-12-31ProductServices249,381,000USD0001217234-26-000018
    Q3 2024Quarterly · 2024-09-30GeographyEurope2,515,000USD0001217234-24-000103
    Q3 2024Quarterly · 2024-09-30GeographyRest of World1,286,000USD0001217234-24-000103
    Q3 2024Quarterly · 2024-09-30GeographyUnited States79,082,000USD0001217234-24-000103
    Q3 2024Quarterly · 2024-09-30ProductPatient And Digital Solutions11,864,000USD0001217234-25-000063
    Q3 2024Quarterly · 2024-09-30ProductProduct10,212,000USD0001217234-25-000063
    Q3 2024Quarterly · 2024-09-30ProductServices60,807,000USD0001217234-25-000063
    Q2 2024Quarterly · 2024-06-30GeographyEurope2,861,000USD0001217234-24-000083
    Q2 2024Quarterly · 2024-06-30GeographyRest of World1,445,000USD0001217234-24-000083
    Q2 2024Quarterly · 2024-06-30GeographyUnited States87,968,000USD0001217234-24-000083
    Q1 2024Quarterly · 2024-03-31GeographyEurope2,309,000USD0001217234-24-000064
    Q1 2024Quarterly · 2024-03-31GeographyRest of World1,230,000USD0001217234-24-000064
    Q1 2024Quarterly · 2024-03-31GeographyUnited States68,510,000USD0001217234-24-000064
    FY 2023Yearly · 2023-12-31GeographyEurope10,167,000USD0001217234-25-000012
    FY 2023Yearly · 2023-12-31GeographyRest of World4,527,000USD0001217234-25-000012
    FY 2023Yearly · 2023-12-31GeographyUnited States265,630,000USD0001217234-25-000012
    FY 2023Yearly · 2023-12-31ProductPatient And Digital Solutions37,122,000USD0001217234-26-000018
    FY 2023Yearly · 2023-12-31ProductProduct33,517,000USD0001217234-26-000018
    FY 2023Yearly · 2023-12-31ProductServices209,685,000USD0001217234-26-000018
    FY 2022Yearly · 2022-12-31GeographyEurope9,549,000USD0001217234-25-000012
    FY 2022Yearly · 2022-12-31GeographyRest of World4,701,000USD0001217234-25-000012
    FY 2022Yearly · 2022-12-31GeographyUnited States307,543,000USD0001217234-25-000012
    FY 2022Yearly · 2022-12-31ProductPatient And Digital Solutions28,794,000USD0001217234-25-000012
    FY 2022Yearly · 2022-12-31ProductProduct29,251,000USD0001217234-25-000012
    FY 2022Yearly · 2022-12-31ProductServices263,748,000USD0001217234-25-000012
    FY 2021Yearly · 2021-12-31GeographyEurope9,822,000USD0001217234-24-000033
    FY 2021Yearly · 2021-12-31GeographyRest of World4,566,000USD0001217234-24-000033
    FY 2021Yearly · 2021-12-31GeographyUnited States282,009,000USD0001217234-24-000033
    FY 2021Yearly · 2021-12-31ProductPatient And Digital Solutions10,280,000USD0001217234-24-000033
    FY 2021Yearly · 2021-12-31ProductProduct26,832,000USD0001217234-24-000033
    FY 2021Yearly · 2021-12-31ProductServices259,285,000USD0001217234-24-000033
    FY 2020Yearly · 2020-12-31GeographyEurope7,562,000USD0001217234-23-000046
    FY 2020Yearly · 2020-12-31GeographyRest of World3,129,000USD0001217234-23-000046
    FY 2020Yearly · 2020-12-31GeographyUnited States181,503,000USD0001217234-23-000046
    FY 2020Yearly · 2020-12-31ProductPatient And Digital Solutions9,282,000USD0001217234-23-000046
    FY 2020Yearly · 2020-12-31ProductProduct19,302,000USD0001217234-23-000046
    FY 2020Yearly · 2020-12-31ProductServices163,610,000USD0001217234-23-000046
    FY 2019Yearly · 2019-12-31GeographyEurope7,790,000USD0001217234-22-000056
    FY 2019Yearly · 2019-12-31GeographyRest of World3,082,000USD0001217234-22-000056
    FY 2019Yearly · 2019-12-31GeographyUnited States116,196,000USD0001217234-22-000056
    FY 2019Yearly · 2019-12-31ProductPatient And Digital Solutions4,239,000USD0001217234-22-000056
    FY 2019Yearly · 2019-12-31ProductProduct18,279,000USD0001217234-22-000056
    FY 2019Yearly · 2019-12-31ProductServices104,550,000USD0001217234-22-000056
    FY 2018Yearly · 2018-12-31GeographyEurope7,602,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31GeographyRest of World2,904,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31GeographyUnited States66,063,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31ProductDigital And Other595,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31ProductLicense And Other595,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31ProductProduct15,674,000USD0001217234-21-000046
    FY 2018Yearly · 2018-12-31ProductServices60,300,000USD0001217234-21-000046
    Q2 2018Quarterly · 2018-06-30SegmentPost Transplant14,171,000USD0001564590-18-021123
    Q2 2018Quarterly · 2018-06-30SegmentPre Transplant3,652,000USD0001564590-18-021123
    Q1 2018Quarterly · 2018-03-31SegmentPost Transplant10,746,000USD0001564590-18-013045
    Q1 2018Quarterly · 2018-03-31SegmentPre Transplant3,307,000USD0001564590-18-013045
    FY 2017Yearly · 2017-12-31SegmentPost Transplant33,690,000USD0001564590-18-006584
    FY 2017Yearly · 2017-12-31SegmentPre Transplant14,634,000USD0001564590-18-006584
    Q3 2017Quarterly · 2017-09-30SegmentCare Dx8,319,000USD0001564590-17-023333
    Q3 2017Quarterly · 2017-09-30SegmentOlerup3,872,000USD0001564590-17-023333
    Q2 2017Quarterly · 2017-06-30SegmentPost Transplant8,670,000USD0001564590-18-021123

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.